NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Scripta Therapeutics

Scripta Therapeutics

Private
OxfordHealthcare & Life Scienceshttps://www.scriptatherapeutics.com/

Last Round

Seed

Nov 13, 2025

Total Funding Raised

$12M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Scripta Therapeutics is a techbio company that develops disease-modifying therapeutics for neurodegenerative disorders by modulating transcription factor activity using an AI-driven, biology-first platform.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Medical Imaging

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

techbiodrug discoverytranscription factor modulationlab-in-the-loopneurodegenerative diseaseai drug discoveryai-driven therapeuticscomputational biologysmall molecule discoveryin silico drug discoverytherapeutic pipelinebiotech partnershipgene expression modulationai for pharmadrug discovery platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Scripta Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Scripta Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Scripta Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 13, 2025
View all Funding Rounds

Key People

Founding team and executive leadership

Peter Hamley

Founder And CEO

Founding Team

Scripta Therapeutics Investors

Notable investors and investment history

Scripta Therapeutics investors
InvestorRounds
Oxford Science EnterprisesSeed
YZR CapitalSeed
Oxford University InnovationSeed
University of OxfordSeed
Oxford Science EnterprisesSeed
YZR CapitalSeed
Albion CapitalSeed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 13, 2025

    $12M raised in Seed round.

  • Nov 13, 2025

    Ray Barlow appointed as Non-Executive Director.

View all signals

Scripta Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Scripta Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Scripta Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersOxford
Employee Range20
Year Founded2024
Last FundingNov 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.